Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer

Jacek Mackiewicz1, Urszula Kazimierczak2, Marek Kotlarski2

  • 1Medical Biotechnology, University of Medical Sciences, Poznan, Poland Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland Department of Medical and Experimental Oncology, Clinical Hospital of Poznan University of Medical Sciences, Poznan, Poland jmackiewicz@ump.edu.pl.

Anticancer Research
|May 31, 2015
PubMed
Abstract

Related Concept Videos